{"id":"W6902093402","doi":"10.6084/m9.figshare.14853224.v1","title":"Additional file 1 of Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Altasciences (Canada)","funders":"","keywords":"Immunogenicity; Biosimilar; Insulin glargine; Diabetes mellitus; Insulin; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001206688,0.0002157833,0.000399024,0.00004876273,0.0002016716,0.00002234922,0.0001989957,0.0001861757,0.2605447],"category_scores_gemma":[0.003920196,0.0001118331,0.00004726246,0.0003151724,0.0003061655,0.00008467304,0.0002927229,0.0004039806,0.00001891111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001909294,"about_ca_system_score_gemma":0.000116936,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000227414,"about_ca_topic_score_gemma":0.00001391136,"domain_scores_codex":[0.9986361,0.000342595,0.0003426561,0.0003271263,0.00008301914,0.000268465],"domain_scores_gemma":[0.9959645,0.003265652,0.0001890497,0.0002650448,0.0002902386,0.00002548491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002390022,0.0003730381,0.003530756,0.0002462433,0.0007531236,0.000005767993,0.0001838978,3.126345e-7,0.0006063752,0.00001046868,0.9685883,0.02546271],"study_design_scores_gemma":[0.004726325,0.0009284815,0.2381139,0.003511976,0.0001736644,0.000005242071,0.0005471124,0.0000132653,0.06456806,0.0001615232,0.6867691,0.0004813694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.08168113,0.006124257,1.002743e-7,0.0004859879,0.00001455711,0.0003531906,0.9112775,0.00001324297,0.00005003965],"genre_scores_gemma":[0.2935839,0.0002383562,0.0006545092,0.0005666767,0.00004299458,0.0003718295,0.7044111,0.00002312821,0.0001075313],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.2818192,"threshold_uncertainty_score":0.7401313,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03648264879626843,"score_gpt":0.2728259093846413,"score_spread":0.2363432605883728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}